757 related articles for article (PubMed ID: 18469708)
41. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
Oliva E; Garcia-Miralles N; Vu Q; Young RH
Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
[TBL] [Abstract][Full Text] [Related]
42. Uterine adenosarcomas overgrown by sex-cord-like tumour: report of two cases.
Stolnicu S; Balachandran K; Aleykutty MA; Loghin A; Preda O; Goez E; Nogales FF
J Clin Pathol; 2009 Oct; 62(10):942-4. PubMed ID: 19783725
[TBL] [Abstract][Full Text] [Related]
43. [Sarcomas and mixed mesodermal tumors of the uterus].
Günthert AR
Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
[TBL] [Abstract][Full Text] [Related]
44. Uterine Adenosarcoma.
Pinto A; Howitt B
Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
[TBL] [Abstract][Full Text] [Related]
45. An unusual extrauterine variant of adenosarcoma with multiple recurrences over 16 years.
Benda JA; Veronezi-Gurwell A; Wilcox M; Buller R
Gynecol Oncol; 1994 Apr; 53(1):131-7. PubMed ID: 8175015
[TBL] [Abstract][Full Text] [Related]
46. Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumors.
Sukov WR; Cheville JC; Lager DJ; Lewin JR; Sebo TJ; Lewin M
Hum Pathol; 2007 Sep; 38(9):1432-7. PubMed ID: 17707262
[TBL] [Abstract][Full Text] [Related]
47. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(4):427-34. PubMed ID: 16220232
[TBL] [Abstract][Full Text] [Related]
48. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(3):355-61. PubMed ID: 16010486
[TBL] [Abstract][Full Text] [Related]
49. Immunoprofile of endocervical and endometrial stromal cells and its potential application in localization of tumor involvement.
Barroeta JE; Pasha TL; Acs G; Zhang PJ
Int J Gynecol Pathol; 2007 Jan; 26(1):76-82. PubMed ID: 17197901
[TBL] [Abstract][Full Text] [Related]
50. Uterine tumors with mixed epithelial and mesenchymal elements.
Clement PB; Scully RE
Semin Diagn Pathol; 1988 May; 5(2):199-222. PubMed ID: 2840723
[TBL] [Abstract][Full Text] [Related]
51. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
[TBL] [Abstract][Full Text] [Related]
52. Lipoadenofibroma of the uterine corpus. Report of a new variant of adenofibroma (benign müllerian mixed tumor).
Horie Y; Ikawa S; Kadowaki K; Minagawa Y; Kigawa J; Terakawa N
Arch Pathol Lab Med; 1995 Mar; 119(3):274-6. PubMed ID: 7887783
[TBL] [Abstract][Full Text] [Related]
53. [High-grade sarcoma with areas of mullerian adenosarcoma of the uterus].
Zanotti F; Mussida M; Merlo D; Milesi M; Aletti L
Ann Ostet Ginecol Med Perinat; 1991; 112(1):29-35. PubMed ID: 1656835
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
Jeffers MD; Richmond JA; Macaulay EM
Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
[TBL] [Abstract][Full Text] [Related]
55. Myxoid mixed low-grade endometrial stromal sarcoma and smooth muscle tumor of the uterus. Case report.
Dundr P; Fischerová D; Povýšil C; Cibula D; Zikán M
Cesk Patol; 2012 Apr; 48(2):103-6. PubMed ID: 22716064
[TBL] [Abstract][Full Text] [Related]
56. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.
de Leval L; Waltregny D; Boniver J; Young RH; Castronovo V; Oliva E
Am J Surg Pathol; 2006 Mar; 30(3):319-27. PubMed ID: 16538051
[TBL] [Abstract][Full Text] [Related]
57. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
58. Testicular Sertoli cell tumor with a heterologous sarcomatous component: immunohistochemical assessment of Sertoli cell differentiation.
Gilcrease MZ; Delgado R; Albores-Saavedra J
Arch Pathol Lab Med; 1998 Oct; 122(10):907-11. PubMed ID: 9786352
[TBL] [Abstract][Full Text] [Related]
59. BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall.
Muthukumarana V; Fix DJ; Stolnicu S; Park KJ; Soslow RA; Benayed R; Ladanyi M; Antonescu CR; Chiang S
Am J Surg Pathol; 2020 Jun; 44(6):765-770. PubMed ID: 32011345
[TBL] [Abstract][Full Text] [Related]
60. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
